LBTYA

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 6

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,794

Underlying: Class A Ordinary Shares · 53,794 shares

Expires 2024-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 5

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 53,794 shares

Expires 2021-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 4

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 511,414

Underlying: Class C Ordinary Shares · 511,414 shares

Expires 2031-04-13

F3 · derivative.exercise_date: The Share Appreciation Rights vest 50% on May 1, 2023 and 50% on May 1, 2024.

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 3

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,707

Underlying: Class A Ordinary Shares · 255,707 shares

Expires 2031-04-13

F3 · derivative.exercise_date: The Share Appreciation Rights vest 50% on May 1, 2023 and 50% on May 1, 2024.

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 2

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,044

Underlying: Class C Ordinary Shares · 56,044 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000130 · wf-form4_161852319834097.xml · derivative · entry 1

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,022

Underlying: Class A Ordinary Shares · 28,022 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 8

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,274

Underlying: Class C Ordinary Shares · 4,274 shares

Expires 2025-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 7

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 4,274 shares

Expires 2022-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 6

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,152

Underlying: Class A Ordinary Shares · 2,152 shares

Expires 2025-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 5

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 2,152 shares

Expires 2022-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 4

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,690

Underlying: Class A Ordinary Shares · 5,690 shares

Expires 2024-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 3

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 5,690 shares

Expires 2021-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 2

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,858

Underlying: Class A Ordinary Shares · 2,858 shares

Expires 2024-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000128 · wf-form4_161852304120958.xml · derivative · entry 1

RAPLEY DAVID E · CIK 0001195192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 2,858 shares

Expires 2021-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000123 · wf-form4_161852273307775.xml · derivative · entry 4

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 639,268

Underlying: Class C Ordinary Shares · 639,268 shares

Expires 2031-04-13

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000123 · wf-form4_161852273307775.xml · derivative · entry 3

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,634

Underlying: Class A Ordinary Shares · 319,634 shares

Expires 2031-04-13

F3 · derivative.exercise_date: The Share Appreciation Rights vest 50% on May 1, 2023 and 50% on May 1, 2024.

SEC source: 0001570585-21-000123 · wf-form4_161852273307775.xml · derivative · entry 2

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,054

Underlying: Class C Ordinary Shares · 70,054 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000123 · wf-form4_161852273307775.xml · derivative · entry 1

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,027

Underlying: Class A Ordinary Shares · 35,027 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 12

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,955

Underlying: Class C Ordinary Shares · 36,955 shares

Expires 2025-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 11

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 36,955 shares

Expires 2022-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 10

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,328

Underlying: Class A Ordinary Shares · 18,328 shares

Expires 2025-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 9

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 18,328 shares

Expires 2022-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 8

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,831

Underlying: Class C Ordinary Shares · 46,831 shares

Expires 2024-05-14

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 7

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 46,831 shares

Expires 2021-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 6

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,535

Underlying: Class A Ordinary Shares · 23,535 shares

Expires 2024-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 5

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 23,535 shares

Expires 2021-05-01

F4 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F4 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding share appreciation rights were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new share appreciation right is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F5 · derivative.exercise_date: Vesting and exercise of the existing share appreciation right has not changed as a result of the extension and therefore the share appreciation right continues to be immediately exercisable.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 4

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 639,268

Underlying: Class C Ordinary Shares · 639,268 shares

Expires 2031-04-13

F3 · derivative.exercise_date: The Share Appreciation Rights vest 50% on May 1, 2023 and 50% on May 1, 2024.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 3

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,634

Underlying: Class A Ordinary Shares · 319,634 shares

Expires 2031-04-13

F3 · derivative.exercise_date: The Share Appreciation Rights vest 50% on May 1, 2023 and 50% on May 1, 2024.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 2

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,054

Underlying: Class C Ordinary Shares · 70,054 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000129 · wf-form4_161852309939979.xml · derivative · entry 1

Salvato Andrea · CIK 0001778743 · SVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,027

Underlying: Class A Ordinary Shares · 35,027 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2022.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 9

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,560

Underlying: Class C Ordinary Shares · 52,560 shares

Expires 2025-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 8

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 52,560 shares

Expires 2022-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 7

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,067

Underlying: Class A Ordinary Shares · 26,067 shares

Expires 2025-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 6

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 26,067 shares

Expires 2022-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 5

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,393

Underlying: Class C Ordinary Shares · 41,393 shares

Expires 2024-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 4

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 41,393 shares

Expires 2021-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 3

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,802

Underlying: Class A Ordinary Shares · 20,802 shares

Expires 2024-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 2

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 20,802 shares

Expires 2021-05-01

F2 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000125 · wf-form4_161852284168269.xml · derivative · entry 1

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,453

Underlying: Class C Ordinary Shares · 233,453 shares

Expires 2031-04-13

F1 · derivative.exercise_date: The option vests in three equal annual installments commencing on April 13, 2022.

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,463

Underlying: Class C Ordinary Shares · 34,462 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,231

Underlying: Class A Ordinary Shares · 17,231 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · nonDerivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,606

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · nonDerivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · nonDerivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,790

SEC source: 0001570585-21-000088 · wf-form4_161765841890390.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-21-000089 · wf-form4_161765852104213.xml · derivative · entry 8

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,594

Underlying: Class C Ordinary Shares · 143,594 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-21-000089 · wf-form4_161765852104213.xml · derivative · entry 7

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,797

Underlying: Class A Ordinary Shares · 71,797 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-21-000089 · wf-form4_161765852104213.xml · nonDerivative · entry 4

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,255,487

SEC source: 0001570585-21-000089 · wf-form4_161765852104213.xml · nonDerivative · entry 3

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,319,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-21-000089 · wf-form4_161765852104213.xml · nonDerivative · entry 2

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 890,402